A quantitative analysis of adverse events and "overwarning" in drug labeling

Arch Intern Med. 2011 May 23;171(10):944-6. doi: 10.1001/archinternmed.2011.182.
No abstract available

MeSH terms

  • Adverse Drug Reaction Reporting Systems / standards*
  • Adverse Drug Reaction Reporting Systems / trends
  • Drug Labeling / standards*
  • Drug Labeling / trends
  • Evaluation Studies as Topic*
  • Humans
  • Product Surveillance, Postmarketing / standards
  • Total Quality Management
  • United States
  • United States Food and Drug Administration